However, SI113-mediated SGK1 inhibition appears to be effective in inducing cell death in RKO cells and potentiating paclitaxel sensitivity, indicating that this new molecule could be efficiently employed, alone or in combination with paclitaxel, in colon cancer chemotherapy (67). The gene discussed is SGK1; the disease is malignant colon neoplasm.